Condition

Fontan Circulation clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Fontan Circulation clinical trials that are recruiting, in United States. By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Fontan Circulation clinical trials

StudyPhaseWhereStatusRegistered
Venous Compression for Fontan Patients — Dallas, Texas Recruiting Oct 23, 2025
Dapagliflozin treatment for adults with failing Fontan circulation Phase 2 Rochester, Minnesota Recruiting Jan 8, 2025
Improving drug dosing for patients with Fontan circulation and liver disease Phase 1 Kansas City, Missouri Recruiting Mar 22, 2024

All recruiting trials (3)

Related topics

HFpEF - Heart Failure With Preserved Ejection FractionSingle-ventricleSingle Ventricle Heart Disease

Quick answers

How many Fontan Circulation clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.